Fulcrum Therapeutics, Inc. earnings per share and revenue

FULC earnings per share for the last quarter are -0.35 USD whereas the estimation was -0.40 USD which accounts for 11.67% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -0.30 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of FULC earnings per share and revenue dynamics.